Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I C Macdougall

Showing results (11-20 of 93) with videos related to

Pageof 10
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
How to get the best out of r-HuEPOI C Macdougall
Przeglad Lekarski|December 19, 1998
Iron therapy: overview and recommendationsI C Macdougall
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2001
Ace inhibitors and erythropoietin responsivenessI C Macdougall
Blood Purification|January 11, 2001
Should the hematocrit be normalized in dialysis and in pre-ESRD patients?I C Macdougall
Kidney International. Supplement|March 20, 1999
Strategies for iron supplementation: oral versus intravenousI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2000
Intravenous administration of iron in epoetin-treated haemodialysis patients--which drugs, which regimen?I C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2001
An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)I C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Poor response to erythropoietin: practical guidelines on investigation and managementI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietinI C Macdougall
Pageof 10

Showing results (11-20 of 93) with videos related to

Sort By:
Pageof 10
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 1999
The role of ACE inhibitors and angiotensin II receptor blockers in the response to epoetinI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
How to get the best out of r-HuEPOI C Macdougall
Przeglad Lekarski|December 19, 1998
Iron therapy: overview and recommendationsI C Macdougall
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|September 5, 2001
Ace inhibitors and erythropoietin responsivenessI C Macdougall
Blood Purification|January 11, 2001
Should the hematocrit be normalized in dialysis and in pre-ESRD patients?I C Macdougall
Kidney International. Supplement|March 20, 1999
Strategies for iron supplementation: oral versus intravenousI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 10, 2000
Intravenous administration of iron in epoetin-treated haemodialysis patients--which drugs, which regimen?I C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2001
An overview of the efficacy and safety of novel erythropoiesis stimulating protein (NESP)I C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1995
Poor response to erythropoietin: practical guidelines on investigation and managementI C Macdougall
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 5, 1998
Meeting the challenges of a new millennium: optimizing the use of recombinant human erythropoietinI C Macdougall
Pageof 10